Quick context
5-Amino-1MQ
并非肽类。主要用于脂肪细胞与能量代谢的临床前研究；缺乏可靠人体数据。
This entry is not a single peptide, or its use depends on diagnosis, product form or composition. A blanket peptide dose would be misleading.
Back to all 64 profiles
No uniform peptide protocol未获 FDA/EMA 批准
Community protocol · 5-Amino-1MQ
5-Amino-1MQ: community information and evidence, clearly separated.
A complete substance profile covering documented community themes, scientific context and explicit safety boundaries. Missing or non-standardised data are not replaced with estimates.
Also known as: 5-amino-1-methylquinolinium · NNMT inhibitor
Sources checked: 27 August 2026
重要安全与责任声明
本页记录并评估网络社区信息，不构成医疗或治疗建议、个体咨询，也不是使用邀请。
No medical, therapeutic or individual recommendation. Information is provided without warranty and used at your own risk. No liability for calculation errors, use, contamination, interactions or consequences.
Amounts, timing and cycles
No uniform peptide protocol
This entry is not a single peptide, or its use depends on diagnosis, product form or composition. A blanket peptide dose would be misleading.
Amount status
Different amounts circulate online; no regulator-confirmed safe or effective dose exists.
Profile evidence level: preclinical.
Timing
Community claims about time of day, fasting windows or training intervals are not validated clinical standards.
No individual recommendation.
Cycle/duration
Cycles and breaks are community constructs and do not prevent adverse effects or unknown long-term consequences.
No individual recommendation.
External community reference available
The external page is used only to document community claims. Advertising and affiliate material were excluded; its content is neither approval nor proof of quality.
Open community source复配与 U-100 换算
No generic calculator
Reconstitution is not generally applicable to this substance or product class. Form, concentration and handling must come from the exact authentic product and its official labelling.
Reconstitution is not generally applicable to this substance or product class. Form, concentration and handling must come from the exact authentic product and its official labelling.
Mechanism and research questions
Experimental small-molecule inhibitor of nicotinamide N-methyltransferase
5-Amino-1MQ is classified as “Experimental small-molecule inhibitor of nicotinamide N-methyltransferase”. 并非肽类。主要用于脂肪细胞与能量代谢的临床前研究；缺乏可靠人体数据。 This describes the investigated pathway but does not validate a community use, amount, route or combination.
NNMT抑制
这项研究考察抑制一种名为NNMT的代谢酶如何影响脂肪细胞的能量消耗,类似于移除刹车装置。在细胞模型中测量酶活性和代谢标志物。
脂肪细胞代谢
这项研究考察脂肪细胞如何储存、释放和燃烧能量,类似于观察储罐如何注满和排空。研究人员通常在细胞或动物模型中测量脂肪细胞大小、酶活性和能量消耗。
细胞能量代谢
研究人员研究细胞如何通过线粒体产生和使用能量,类似于测量发动机燃烧燃料的效率。常见测量指标包括细胞模型中的耗氧量和能量输出。
What communities discuss
These themes describe discussion and vendor claims. They do not prove benefit, safety, product identity or suitable use.
体重管理论坛
在这些论坛中,用户比较不同产品之间自己的体重变化、副作用以及感知到的食欲变化。经常会分享前后对比照片和个人时间线。这类轶事和商家营销宣传并不是科学的疗效证明。
生物黑客与长寿论坛
用户比较自行组合的肽方案,以期影响衰老过程或能量水平,常常依据血液检测或主观幸福感量表。个人自我实验和营销承诺无法取代对照的长期人体研究。
来源与纯度讨论
人们讨论哪些商家被认为更值得信赖,以及不同批次之间纯度检测结果的差异。这类社区评估基于有限的样本,无法替代对每一批次进行的独立实验室检测。
Adverse effects and risk boundaries
- 根据靶点，可能出现胃肠道反应、脱水以及血糖或食欲变化；肠促胰素类药物还可能涉及胆囊、胰腺和视网膜病变警示。
- Local reaction, infection, abscess and contamination are possible with any injection that is not professionally manufactured and administered.
- A label or clear appearance does not exclude unknown purity, wrong identity, endotoxins or concentration errors.
Exclusion groups and professional assessment
- 妊娠、严重胃排空障碍以及相关胰腺、胆囊、肾脏或内分泌疾病均需专业评估；具体说明书还可能列出其他禁忌。
- Acute symptoms, allergic reaction, breathing difficulty, chest pain, neurological deficits or severe abdominal pain require immediate medical care.
- Children and adolescents, pregnancy/breastfeeding, and people with relevant disease should not be part of unsupervised experiments.
Monitoring and laboratory markers
- 根据物质和适应证，可评估体重、血压、水合状态、血糖/HbA1c、肝肾指标及合并用药；其他检查由症状决定。
- Baseline, objective, measurement timing and stop criteria must be defined professionally in advance. Individual laboratory values cannot compensate for unknown product quality.
Evidence boundary
临床前
尚未证实其在人体中具有可靠的疗效和安全性。
Published evidence
现有数据主要来自动物或细胞模型;缺乏可靠的人体有效性和安全性数据。
5-氨基-1MQ并非肽类物质,而是一种小分子NNMT抑制剂,不同于基于肽的代谢候选药物。
Storage and stability
- The manufacturer label and prescribing information take priority. Storage instructions from a different product do not transfer.
- Unapproved vials often lack dependable stability data before and after mixing; ‘2–8 °C’ or ‘28 days’ is not a universal standard.
- Do not use after seal damage, particles, cloudiness, discoloration, unknown date or interrupted cold chain. Visual inspection does not prove sterility.
Troubleshooting and error sources
- U-100 units measure volume, not drug amount: 100 U equals 1 mL. A wrong concentration makes every unit figure wrong.
- Do not shake or dilute further to ‘fix’ cloudiness, particles or uncertain solubility; discard and obtain professional clarification.
- Do not calculate a double or extra amount to compensate for missed use or an uncertain injection.
- Without a COA, clear supplier, correct label and consistent vial information, identity is not confirmed.
Regulatory status and WADA
未获 FDA/EMA 批准
没有 FDA 或 EMA 批准的药品；有效性与安全性尚未确立。
WADA 2026
The atlas has no explicit WADA flag for this profile. That does not automatically mean every form, route or related class is permitted in sport.
WADA — 2026 Prohibited ListComparisons and related profiles
Combinations / stacks
- Combinations change effects, adverse effects and laboratory values; evidence for one substance does not establish the safety of a stack.
- Overlapping pathways may add up. Hormonal, glucose, blood-pressure, coagulation, immune and sedating effects are important potential interactions.
- Non-standardised blends prevent separate dosing, cause attribution and dependable reconstitution.
Frequently asked questions
Is an amount shown here a recommendation?
No. This page separates approved product information, study protocols and community information. No number or calculator is an individual dosing recommendation.
Does the U-100 calculator prove correct use?
No. It only converts mass, volume and syringe scale. It cannot check identity, purity, sterility, stability, solvent or medical suitability.
Can this profile be combined with other substances?
Safety of a combination cannot be inferred from a single-substance profile. Overlapping pathways, medicines and undefined blends can increase risk.
Which source controls when information conflicts?
For approved medicines, the current prescribing information and treating professional control. For research substances, conflict shows that no dependable self-use standard exists.
Are community claims clinical evidence?
No. Anecdotes can generate questions but do not replace controlled studies, regulatory review, or identity and quality testing.
Sources and evidence layers
Primary sources and official registries take priority. The community reference is labelled separately.
- Primary/technical sourcePubMed: 5-amino-1MQ literature search
- Primary/technical sourceFDA — GenoGenix warning letter (5-Amino-1MQ)
- Community reference5-Amino-1MQ — Peptide Dosing Protocols